FDA clears Watson generic of Wellbutrin XL antidepressant

06/13/2007 | Forbes

Watson Pharmaceuticals says it has won FDA approval for its generic of Wellbutrin XL, the antidepressant made by Biovail Corp. and sold by GlaxoSmithKline. Watson said it plans to market its extended-release version immediately.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Claims Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Vice President, Idaho Regional Director
Boise, ID